Inari Medical, Inc.
NARI
Ранг среди акций
#3686
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Цена акции
$79.97
Последняя синхронизация: 2025-02-19
Рыночная капитализация
$4.57B
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Inari Medical, Inc. (NARI)
Категория
Healthcare
Выручка компании Inari Medical, Inc. (NARI)
Выручка на Sep 2024 TTM: $574.50M
Согласно последним финансовым отчетам Inari Medical, Inc., текущая выручка компании (TTM) составляет $574.50M. В 2022 году компания получила выручку $383.47M больше, чем выручке в 2021 году, которая составила $276.98M. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Inari Medical, Inc. с 2018 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $574.50M | 16.38% |
| 2023 | $493.63M | 28.73% |
| 2022 | $383.47M | 38.45% |
| 2021 | $276.98M | 98.31% |
| 2020 | $139.67M | 173.17% |
| 2019 | $51.13M | 648.70% |
| 2018 | $6.83M | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| $46.59B | 8,008.82% |
US
|
|
| $35.48B | 6,076.52% |
IE
|
|
| $25.84B | 4,397.32% |
US
|
|
| $21.00B | 3,554.67% |
US
|
|
| - | - |
DE
|
